Routine

Outpatient parenteral antimicrobial therapy (OPAT)

OPAT · Infectious Disease
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

OPAT delivers intravenous (or complex oral) antimicrobials outside hospital for infections needing prolonged therapy, enabling early discharge. Safe delivery needs careful patient selection, stable infection, vascular access and structured monitoring with specialist oversight.

Red flags

  • New fever, rigors or line-site inflammation (line infection)
  • Signs of treatment failure or progression
  • Drug toxicity (rising creatinine, cytopenias, rash)
  • Catheter occlusion/thrombosis
  • Clinical deterioration requiring readmission

Assessment

Differential diagnosis

  • Infection suitable for early oral switch (may not need OPAT)
  • Infection too unstable for ambulatory care
  • Deep infection needing source control first
  • Social/cognitive barriers precluding home therapy
  • Line-related complications

Investigations

  • Confirmed microbiological diagnosis and susceptibilities
  • Baseline FBC, renal and liver function
  • Assessment of vascular access options (midline/PICC)
  • Infection-specific markers for monitoring (CRP, imaging)
  • Drug level monitoring plan (e.g. vancomycin, aminoglycosides)
  • Review of social suitability and support

Management

  • Confirm the infection needs prolonged parenteral therapy and is stable for ambulatory care
  • Ensure source control achieved where required
  • Select an antimicrobial suited to once-daily or infusion-device delivery where possible
  • Establish appropriate vascular access (PICC/midline)
  • Agree a monitoring schedule for efficacy, toxicity and drug levels
  • Educate patient/carer on line care and red-flag symptoms
  • Set up clear governance with ID/OPAT team oversight and emergency pathways
  • Deliver therapy via community nurses, self-administration or clinic
  • Review regularly (clinical, bloods, drug levels) and adjust
  • Plan step-down to oral therapy as soon as appropriate (e.g. per OVIVA for bone/joint)
  • Document completion and arrange follow-up imaging/markers
  • Remove the line promptly at end of therapy

Drugs & doses

Ceftriaxone 2 g IV once daily (convenient once-daily agent for OPAT)
Ertapenem 1 g IV once daily (ESBL/complex infections)
Teicoplanin or daptomycin once daily for Gram-positive infection (dosed to weight/levels)
Dalbavancin (long-acting lipoglycopeptide) for selected Gram-positive infections reducing visits

Disposition

Ambulatory/home under OPAT service with ID oversight; readmit for complications.

Complications & pitfalls

  • Line-associated bloodstream infection and thrombosis
  • Drug toxicity (nephro/oto/marrow)
  • Treatment failure/relapse
  • Clostridioides difficile infection
  • Readmission

Exam pearls

  • Once-daily agents (ceftriaxone, ertapenem, teicoplanin, daptomycin) simplify OPAT
  • Long-acting agents (dalbavancin) can minimise visits for Gram-positive infection
  • Switch to oral as soon as evidence supports it - OPAT is not automatically superior
  • Robust governance and monitoring are essential for safety
  • Address social suitability and line care education before discharge

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.